Skip to search formSkip to main contentSkip to account menu

Efavirenz:MCnc:Pt:Ser/Plas:Qn

Known as: Efavirenz:MCnc:Pt:Sor/Plas:Qn, Efavirenz:MCnc:Pt:Siero/Plasma:Qn, Efavirenz:Mass Concentration:Point in time:Serum/Plasma:Quantitative 
National Institutes of Health

Related topics

Related topics

4 relations
PlasSerumUnit of Mass Concentrationefavirenz

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Eine radiologische und anatomische Untersuchung von intralaminären Schrauben in der Brustwirbelsäule - eine theoretische Machbarkeitsstudie
Failure of pedicle screws and anatomical variations which prevent pedicle screw implantation make the search for an alternative… 
2019
2019
Perbandingan Penggunaan Efavirenz dan Nevirapine Terhadap Kolesterol LDL Pasien HIV/AIDS
Gangguan metabolik lipid merupakan kondisi yang sering ditemukan pada pasien HIV (Human Immunodeficiency Virus)/AIDS (Acquired… 
2017
2017
Prevalence and Clinical Spectrum of Liver Disease in Nepalese HIV-Sero-Positive Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Hospital Based Study
Introduction Liver enzyme abnormalities are common in HIV patients, and the prevalence varies across the nations. In Nepal… 
2015
2015
Enhanced normalisation of CD 4 / CD 8 ratio with early antiretroviral therapy in primary HIV infection
Weight-Adjusted LNG Concentrations Weight was a predictor of LNG concentrations (1kg increase in weight = 5pg/mL decrease in LNG… 
2010
2010
Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers
Background The efflux transporter MRP1 actively transports antiretrovirals and reduces intracellular accumulation in peripheral… 
2008
2008
Patrones de prescripción de antirretrovirales en 997 pacientes colombianos
Introduccion. El tratamiento antirretroviral de la infeccion por virus de inmunodeficiencia humana ha mejorado la supervivencia y… 
2006
2006
Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.
OBJECTIVES To assess the safety and efficacy of efavirenz 800 mg daily in HIV-infected patients with tuberculosis receiving a… 
2006
2006
Ernstige psychose bij een Afrikaanse vrouw door het antiretrovirale middel efavirenz
Highly Cited
2001
Highly Cited
2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy
BackgroundEnhanced susceptibility to non-nucleoside reverse transcriptase inhibitors (NNRTI) was recently described in… 
1998
1998
Soaring prices, soaring sales.
DuPont Pharmaceuticals and Glaxo Wellcome began marketing two new drugs, and the pricing of the drugs started a controversy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)